Divi’s Labs Q1 preview: Strong topline growth, margin expansion

Divi’s Laboratories, India’s second-largest pharma company by market cap, is expected to report impressive revenue and profit growth, and robust margin expansion for the April-June quarter. 

​Divi’s Laboratories, India’s second-largest pharma company by market cap, is expected to report impressive revenue and profit growth, and robust margin expansion for the April-June quarter.